Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Japanese Males
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
To assess the safety and tolerability of ascending single oral doses of SAM-531, an
investigational drug, in healthy Japanese male subjects. Secondary: To obtain preliminary
pharmacokinetic (PK) and pharmacodynamic (PD) profiles of SAM-531 in healthy Japanese male
subjects.